Caribou Biosciences, Inc.CRBUNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
48.28%
↑ 314% above average
Average (22q)
-22.54%
Historical baseline
Range
High:80.66%
Low:-328.36%
Volatility
-1814.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 48.28% |
| Q2 2025 | -34.88% |
| Q1 2025 | -10.26% |
| Q4 2024 | -2.63% |
| Q3 2024 | 9.52% |
| Q2 2024 | 8.70% |
| Q1 2024 | -17.95% |
| Q4 2023 | -225.00% |
| Q3 2023 | 75.00% |
| Q2 2023 | -4.35% |
| Q1 2023 | -4.55% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | -37.50% |
| Q1 2022 | -3.23% |
| Q4 2021 | 32.61% |
| Q3 2021 | -76.92% |
| Q2 2021 | 45.83% |
| Q1 2021 | 9.43% |
| Q4 2020 | -82.76% |
| Q3 2020 | -328.36% |
| Q2 2020 | 80.66% |
| Q1 2020 | 0.00% |